Skip to content

Pathophysiology of speech rhythm disorders in Parkinson's disease patients treated with deep brain stimulation -Comparisons with speech symptoms of other neurological disorders-

Pathophysiology of speech rhythm disorders in Parkinson's disease patients treated with deep brain stimulation -Comparisons with speech symptoms of other neurological disorders- - Speech rhythm disorders after deep brain stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000028596
Enrollment
100
Registered
2017-08-29
Start date
2017-11-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

In cross-sectional study, we assess the speech of participants. The correlation between characteristics of speech in Parkinson&#39
s disease patients and other patients is analyzed. Parkinson&#39
s disease patients treated only with medical therapy. Cerebellar disease patients. Patients of upper motor neuron disease. Patients of lower motor neuron disease.

Sponsors

Nagoya university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Parkinson's disease patients who undergo deep brain stimulation in Nagoya university hospital. 2. Patients of cerebellar and upper/lower motor neuron disease in Nagoya university hospital.

Exclusion criteria

Exclusion criteria: Patients with further neurological disease, severe cognitive impairment or psychiatric disorders that may hinder the assessment.

Design outcomes

Primary

MeasureTime frame
Characteristics of speech rhythm disturbance in Parkinson's disease patients differs from the cerebellar, upper/lower motor neuron disorders patients. Acoustically, we'll use the syllable repetition /pa/. To assess the speech intelligibility and speech characteristics we use perceptual assessment.

Countries

Japan

Contacts

Public ContactYasuhiro Tanaka

Nagoya University Graduate School of Medicine Department of Neurology

tanaka.yasuhiro@i.mbox.nagoya-u.ac.jp052-744-2391

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026